Leucht S - Search Results

1

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.

Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Furukawa TA, et al. Among authors: leucht s. Lancet Psychiatry. 2019 Jul;6(7):601-609. doi: 10.1016/S2215-0366(19)30217-2. Epub 2019 Jun 6. Lancet Psychiatry. 2019. PMID: 31178367 Free PMC article.

2

Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale.

Furukawa TA, Katherine Shear M, Barlow DH, Gorman JM, Woods SW, Money R, Etschel E, Engel RR, Leucht S. Furukawa TA, et al. Among authors: leucht s. Depress Anxiety. 2009;26(10):922-9. doi: 10.1002/da.20532. Depress Anxiety. 2009. PMID: 19006198 Free PMC article.

3

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.

Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Leucht S, et al. Lancet. 2009 Jan 3;373(9657):31-41. doi: 10.1016/S0140-6736(08)61764-X. Epub 2008 Dec 6. Lancet. 2009. PMID: 19058842

4

Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials.

Furukawa TA, Akechi T, Wagenpfeil S, Leucht S. Furukawa TA, et al. Among authors: leucht s. Schizophr Res. 2011 Mar;126(1-3):212-9. doi: 10.1016/j.schres.2010.10.016. Epub 2010 Nov 9. Schizophr Res. 2011. PMID: 21062670 Free article.

5

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology.

Barnes TR; Schizophrenia Consensus Group of British Association for Psychopharmacology. Barnes TR, et al. J Psychopharmacol. 2011 May;25(5):567-620. doi: 10.1177/0269881110391123. Epub 2011 Feb 3. J Psychopharmacol. 2011. PMID: 21292923

6

How to obtain NNT from Cohen's d: comparison of two methods.

Furukawa TA, Leucht S. Furukawa TA, et al. Among authors: leucht s. PLoS One. 2011 Apr 27;6(4):e19070. doi: 10.1371/journal.pone.0019070. PLoS One. 2011. PMID: 21556361 Free PMC article.

7

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.

Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, Davis JM. Leucht S, et al. Lancet. 2012 Jun 2;379(9831):2063-71. doi: 10.1016/S0140-6736(12)60239-6. Epub 2012 May 3. Lancet. 2012. PMID: 22560607

8

Can we inflate effect size and thus increase chances of producing "positive" results if we raise the baseline threshold in schizophrenia trials?

Furukawa TA, Leucht S. Furukawa TA, et al. Among authors: leucht s. Schizophr Res. 2013 Mar;144(1-3):105-8. doi: 10.1016/j.schres.2012.12.006. Epub 2013 Jan 9. Schizophr Res. 2013. PMID: 23312551 Free article.

9

Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis.

Spineli LM, Higgins JP, Cipriani A, Leucht S, Salanti G. Spineli LM, et al. Among authors: leucht s. Clin Trials. 2013;10(3):378-88. doi: 10.1177/1740774512470317. Epub 2013 Jan 15. Clin Trials. 2013. PMID: 23321265

10

Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials.

Dold M, Li C, Gillies D, Leucht S. Dold M, et al. Among authors: leucht s. Eur Neuropsychopharmacol. 2013 Sep;23(9):1023-33. doi: 10.1016/j.euroneuro.2013.03.001. Epub 2013 Apr 17. Eur Neuropsychopharmacol. 2013. PMID: 23602690 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters